Full-Time

Regional Business Director

Oncology

Posted on 9/4/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$235k - $274kAnnually

Expert

Remote in USA

Category
Strategic Account Management
Sales & Account Management
Required Skills
Branding/Brand Strategy
Requirements
  • Proven experience in successfully launching key products/brands in the oncology field
  • Has a track record in launching and managing sales of oncology products, particularly in the GYN/ONC therapeutic area
  • Previous success building and leading high-performing teams
  • Inspirational leadership style with the ability to motivate and encourage accountability
  • Strategic thinker with strong business acumen and the ability to translate strategy into actionable sales plans
  • Bachelor’s degree plus 10+ years of commercial experience in pharmaceuticals
  • Extensive understanding and experience in both clinical aspects and the business of oncology, with a focus on gyne/onc
  • In-depth knowledge of U.S. payer and market access dynamics
Responsibilities
  • Cultivate a ‘high trust’ culture that inspires excellence, puts people first, and works together to bring out the best in individuals with an unwavering commitment to patients
  • Collaborate with cross-functional leaders and teams to develop comprehensive brand and sales strategies. Lead the execution of these strategies to drive revenue growth and market share within their Region
  • Work with Vice President, Oncology, Human Resources and Talent Acquisition to lead the recruitment, development, and retention of top-tier talent
  • Execute the launch plans to ensure a successful market introduction and rapid adoption of new products
  • Establish sales goals and monitor performance against targets
  • Identify and prioritize key accounts, including oncologists, hospitals, and cancer treatment centers
  • Build and maintain strong relationships with key opinion leaders (KOLs), healthcare professionals, and other stakeholders in the GYN/ONC therapeutic area
  • Conduct market analysis to understand regional trends, competitive landscape, and customer needs
  • Collaborate with marketing, medical affairs, and other cross-functional teams to align strategies and ensure consistent messaging

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Company Stage

IPO

Total Funding

$39.7M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

3%

1 year growth

2%

2 year growth

-3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.
  • Advancements in drug delivery systems could enhance Corcept's product efficacy.
  • The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

What critics are saying

  • Teva's antitrust lawsuit could lead to legal expenses and market share loss.
  • Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.
  • Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

What makes Corcept Therapeutics unique

  • Corcept specializes in cortisol modulation, a niche with few direct competitors.
  • Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.
  • Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

INACTIVE